Isaac Finger-Baker is a seasoned chemical and materials engineer with over 15 years of experience driving innovation at the intersection of biopharmaceutical research, materials science, and advanced cell culture technologies. As the founder and CEO of Aloft Biotechnologies, Isaac leads the development of next-generation tools designed to accelerate access to advanced cell and gene therapies by enhancing control over cell behavior and microenvironments in 3D culture systems.

Before founding Aloft Biotechnologies in 2024, Isaac held senior R&D roles across the biopharma sector, where he led cross-functional efforts to develop novel bioproduction platforms—including a high-throughput magnetic cell separation system now in commercial beta, as well as innovative downstream platforms for plasmid DNA and viral vector manufacturing. His work spans synthetic biology, microfabrication, magnetic separations, superhydrophobic surface design, and organoid culture systems.

He is most recently recognized for pioneering reproducible 3D culture environments that enable tunable gas exchange and precise modulation of cell-cell interactions—advancing more physiologically relevant models for disease research, drug screening, and regenerative medicine.

A strong advocate for translational science and ethical innovation, Isaac actively explores funding strategies, intellectual property development, and strategic partnerships to scale life-saving biotechnologies. His leadership integrates scientific rigor, systems thinking, and a deep commitment to global health equity.